Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers
NCT ID: NCT00292357
Last Updated: 2010-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
40 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells
NCT03865394
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
NCT02866565
Plasma and Scarring of Diabetic Ulcers
NCT04145154
Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction
NCT02987101
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
NCT02092870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Application of autologous bone marrow
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic non-healing foot ulcers (\>4weeks)
Exclusion Criteria
* Non-diabetic ulcers
* Ulcers healing under conventional therapy
* Sepsis
* Hematologic disorders
* Pregnancy
* Acute inflammatory disorders
* Chemotherapy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Nawroth, MD
Role: PRINCIPAL_INVESTIGATOR
University of Heidelberg, Dept. Medicine 1, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Klinik 1, Universitätsklinikum Heidelberg
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HD-Med1-01/06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.